XM does not provide services to residents of the United States of America.
E
E

Edenred

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Burberry, Experian, GEA Group

EUROPE RESEARCH ROUNDUP- Burberry, Experian, GEA Group Sept 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Burberry, Experian and GEA Group, on Thursday. HIGHLIGHTS * Burberry BRBY.L : RBC cuts target price to 650p from 800p * Experian EXPN.L : RBC raises to sector perform from underperform * FACC AG FACC.VI : Kepler Cheuvreux raises to buy from hold * GEA Group AG G1AG.DE : Morgan Stanley raises to overweight from equal-weight
B
B
B
E
E
G
H
K
K
L
M
P
R
S
S
U
U
P

Anglo American, Mercedes-Benz, Next

EUROPE RESEARCH ROUNDUP- Anglo American, Mercedes-Benz, Next Sept 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Anglo American, Mercedes-Benz and Next, on Monday. HIGHLIGHTS * Anglo American AAL.L : JP Morgan cuts target price to 2,305p from 2,440p * Mercedes-Benz Group AG MBGn.DE : Jefferies cuts target price to EUR 75 from EUR 90 * Next Plc NXT.L : JP Morgan raises target price to 10,500p from 9,900p * Porsche AG P911_p.DE :
B
B
B
C
E
G
G
H
H
H
H
K
L
M
M
N
S
A
A
R

Into H2, JPM prefers Compass, Aramark among caterers

BUZZ-Into H2, JPM prefers Compass, Aramark among caterers ** Going into H2, J.P.Morgan prefers Compass CPG.L and Aramark ARMK.N to France's Sodexo EXHO.PA among caterers, due to stronger performance and contract wins ** JPM points to Compass' ("overweight") outstanding execution and leading scale as well as healthy H2 organic growth and a potential
C
E
J
S

MS picks European travel and leisure stocks for Q4, ups Edenred

BUZZ-MS picks European travel and leisure stocks for Q4, ups Edenred ** Morgan Stanley says there are reasons to be "cheerful" on demand as it names its top picks for Q4 among European travel and leisure stocks ** It notes strong summer hotel data in Europe, normalising hotel data in the U.S. and roboust corporate demand ** "If anything, the consum
A
E
S
W
F

Air Liquide, Novo Nordisk, Syensqo

EUROPE RESEARCH ROUNDUP- Air Liquide, Novo Nordisk, Syensqo Sept 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air Liquide, Novo Nordisk and Syensqo, on Thursday. HIGHLIGHTS * Air Liquide AIRP.PA : Morgan Stanley cuts to underweight from equal-weight * Lanxess AG LXSG.DE : Morgan Stanley raises to overweight from underweight * Novo Nordisk NOVOb.CO : JP Morgan raises target price to DKK 1050 from DKK 950 * Swiss Life Holding AG
A
A
A
A
B
B
C
E
K
L
N
W
A
A
A
S
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.